Search This Blog

Monday, April 22, 2024

FDA approves ImmunityBio's bladder cancer therapy

 The U.S. FDA had approved ImmunityBio's combination therapy to treat a type of bladder cancer, the company said on Monday.

https://www.marketscreener.com/quote/stock/IMMUNITYBIO-INC-23160241/news/US-FDA-approves-ImmunityBio-s-bladder-cancer-therapy-46496606/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.